Modern Surgical Treatments for Thoracic Malignancies

Dear Colleagues,

It is with great pleasure that I have accepted the invitation from Cancers to be the Editor of this Special Issue about the modern surgical treatment of thoracic malignancies. The approach to thoracic tumors has undergone major changes in recent decades, and clinical practice has adjusted accordingly: the dramatic development of minimally invasive techniques and the advances in biomolecular and chemico-pharmacological investigations have led to personalized cancer medicine. The role of the Thoracic Surgeon has therefore changed and the inter-relationships with Oncologists and Radiotherapists in common clinical practice are nowadays increasingly closer. Modern combination studies between chemotherapy, immunotherapy, and biological agents have dramatically re-defined the prognosis of patients with thoracic neoplasms. The surgical techniques required modifications, by adapting to greater technical complexities related to tissue changes as the result of oncological treatments.

This Special Issue of Cancers therefore aims to reiterate this new trend of modern Thoracic Surgery, reaffirming the concept that the treatment of thoracic neoplasms still passes through their radical resection.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• Robotic surgery for lung cancer, thymoma, and mesothelioma.
• Salvage surgery for lung cancer, thymoma, and mesothelioma.
• Hyperthermic intrathoracic chemotherapy for lung cancer, thymoma, and mesothelioma.

I look forward to receiving your contributions.

Prof. Dr. Pier Luigi Filosso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.